ANO5 in Muscle Health and Disease
ANO5 在肌肉健康和疾病中的作用
基本信息
- 批准号:10378023
- 负责人:
- 金额:$ 38.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAllelesAnimal ModelAntibodiesBiochemicalBiological ProcessBiologyClinicalClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsCompetitive BindingDataDefectDevelopmentDimerizationDiseaseDominant-Negative MutationExonsFamilyFrameshift MutationFunctional disorderFundingGenesGeneticHealthHeterodimerizationHumanIntracellular MembranesIowaKnock-outKnockout MiceLeadLinkLipidsMediatingMembraneMembrane ProteinsModelingMolecularMonoclonal AntibodiesMusMuscleMuscle CellsMuscle DevelopmentMuscle FibersMuscular DystrophiesMusculoskeletalMutagenesisMutationMyopathyOrganellesOryctolagus cuniculusPathogenesisPathologicPathologyPatientsPeptidesPhenotypePhosphatidylserinesPhospholipidsPhysiologicalPositioning AttributeProductionProtein FamilyProteinsResearchResearch PersonnelRoleSkeletal MuscleTestingTissuesUniversitiesWild Type Mouseanoctamin 5basecellular imagingconfocal imagingdesignexperimental studygenetic linkagehuman diseaseimaging studyin vivoin vivo evaluationinjury and repairinsightmembermembrane assemblymuscle degenerationmuscle physiologymuscular dystrophy mouse modelmutantnovel therapeutic interventionprematurereconstructionrepairedtreatment strategy
项目摘要
PROJECT SUMMARY
Mutations in ANO5 have been linked to several human diseases including muscular dystrophy. Ano5 is an
intracellular membrane protein, belonging to the anoctamin protein family. Many of the proteins in this family
have been found to possess the Ca2+-activated phospholipid scrambling activity. Despite the clear genetic
linkage between ANO5 and muscular dystrophy in patients, we found that complete KO of Ano5 in mice
showed no overt muscle pathology during our last funding period. This was independently confirmed by other
investigators using a different line of complete Ano5-KO mice. These findings indicate that a potential
compensatory mechanism, likely through other anoctamin proteins, is involved in minimizing the impact of
complete Ano5 deficiency. Intriguingly, an Ano5-KO mouse expressing putatively a truncated Ano5 peptide
developed clinical signs of muscular dystrophy with intracellular aggregates and defective membrane repair.
Many of the ANO5 mutations associated with human muscular dystrophy are premature termination mutations.
These findings raise an interesting question about how ANO5 mutations cause muscle degeneration in human
patients: does the expression of mutant amino-terminal Ano5 peptide lead to muscular dystrophy by promoting
the formation of intracellular aggregates and compromising membrane repair machinery? Our continuing
research in this proposal is centered on determining the fundamental role of the amino-terminus of Ano5 in
regulating the intrinsic lipid scrambling function of anoctamins proteins, membrane repair and its contribution to
the pathogenesis of muscular dystrophy caused by ANO5 mutations. Moreover, our studies will reveal the
compensatory mechanism underlying the lack of muscular dystrophy phenotype in complete Ano5-KO mice.
Through the use of in vivo CRISPR gene editing, biochemical, histopathological, and living cell imaging studies
with animal models, our planned experiments shall advance our understanding of the physiological and
pathological roles of amino-terminal Ano5 peptides in muscle and also shed critical insights into the
development of novel therapeutic strategies for the treatment of Ano5-related muscular dystrophy.
项目摘要
ANO 5的突变与包括肌肉萎缩症在内的多种人类疾病有关。Ano 5是一个
细胞内膜蛋白,属于anoctamin蛋白家族。这个家族中的许多蛋白质
已发现具有Ca 2+激活的磷脂扰乱活性。尽管基因上
ANO 5与肌营养不良症患者之间的联系,我们发现小鼠中ANO 5的完全KO
在上一次资助期间没有明显的肌肉病变这一点得到了其他人的独立证实。
研究人员使用不同系的完全Ano 5-KO小鼠。这些发现表明,
补偿机制,可能通过其他anoctamin蛋白,参与最大限度地减少影响,
完全缺乏Ano 5。有趣的是,表达截短的Ano 5肽的Ano 5-KO小鼠
出现肌营养不良的临床体征,伴有细胞内聚集和膜修复缺陷。
许多与人类肌营养不良症相关的ANO 5突变是过早终止突变。
这些发现提出了一个有趣的问题,即ANO 5突变如何导致人类肌肉退化。
患者:突变氨基末端Ano 5肽的表达是否通过促进
细胞内聚集体的形成和损害膜修复机制?我们继续
这项建议的研究集中在确定Ano 5的氨基末端的基本作用,
调节anoctamins蛋白质的内在脂质扰乱功能,膜修复及其对
ANO 5突变引起的肌营养不良症的发病机制。此外,我们的研究将揭示
在完全Ano 5-KO小鼠中缺乏肌营养不良表型的潜在补偿机制。
通过使用体内CRISPR基因编辑、生物化学、组织病理学和活细胞成像研究
通过动物模型,我们计划的实验将促进我们对生理和
氨基末端Ano 5肽在肌肉中的病理作用,也揭示了
开发治疗Ano 5相关肌营养不良症的新型治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Renzhi Han其他文献
Renzhi Han的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Renzhi Han', 18)}}的其他基金
Base editing of ASGR1 for cardiovascular disease
ASGR1 碱基编辑治疗心血管疾病
- 批准号:
10590146 - 财政年份:2023
- 资助金额:
$ 38.36万 - 项目类别:
Myokine function of MG53 in muscle injury-repair and regeneration
MG53在肌肉损伤修复和再生中的肌因子功能
- 批准号:
10268967 - 财政年份:2017
- 资助金额:
$ 38.36万 - 项目类别:
Molecular and cellular functions of Ano5 in heart
Ano5在心脏中的分子和细胞功能
- 批准号:
8823821 - 财政年份:2015
- 资助金额:
$ 38.36万 - 项目类别:
Molecular and cellular functions of Ano5 in heart
Ano5在心脏中的分子和细胞功能
- 批准号:
9035423 - 财政年份:2015
- 资助金额:
$ 38.36万 - 项目类别:
Molecular and cellular functions of Ano5 in heart
Ano5在心脏中的分子和细胞功能
- 批准号:
8981124 - 财政年份:2015
- 资助金额:
$ 38.36万 - 项目类别:
Mechanisms of Muscle Inflammation in Muscular Dystrophy
肌营养不良症中肌肉炎症的机制
- 批准号:
9271865 - 财政年份:2014
- 资助金额:
$ 38.36万 - 项目类别:
Mechanisms of Muscle Inflammation in Muscular Dystrophy
肌营养不良症中肌肉炎症的机制
- 批准号:
8847225 - 财政年份:2014
- 资助金额:
$ 38.36万 - 项目类别:
Molecular and cellular functions of Ano5 in heart
Ano5在心脏中的分子和细胞功能
- 批准号:
8690963 - 财政年份:2013
- 资助金额:
$ 38.36万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 38.36万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 38.36万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 38.36万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 38.36万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 38.36万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 38.36万 - 项目类别:
Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 38.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 38.36万 - 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 38.36万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 38.36万 - 项目类别: